Impaired T cell function and decreased natural killer activity in patients with liver cirrhosis and their significance in the development of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Impaired T cell function and decreased natural killer activity in patients with liver cirrhosis and their significance in the development of hepatocellular carcinoma

Published:1980-06 Issue:3 Volume:15 Page:226-232
ISSN:0435-1339
Container-title:Gastroenterologia Japonica
language:en
Short-container-title:Gastroenterol Jpn

Author:

Morizane Toshio,Watanabe Tetsu,Tsuchimoto Kanji,Tsuchiya Masaharu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/BF02774272.pdf

Reference35 articles.

1. Sagebiel RW, et al: Primary carcinoma of the liver in relation to cirrhosis. Am J Clin Path 40: 516, 1963

2. Elkington SG, et al: Hepatoma in cirrhosis. Brit Med J. 5371:1501, 1963

3. Gall EA: Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis. AMA Arch Path 70: 226, 1960

4. Lee FI: Cirrhosis and hepatoma in alcoholics. Gut 7: 77, 1966

5. Sherlock S., et al: Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet 1: 1243, 1970

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression;Growth Factors;2016-07-03

2. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer;Biomolecules;2016-05-03

3. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma;Cellular & Molecular Immunology;2014-10-13

4. NK and NKT cells in liver injury and fibrosis;Clinical Immunology;2009-01

5. Impaired natural killer cell cytotoxic activity in chronic hepatitis C viral infection: A single-center, controlled study;Current Therapeutic Research;2002-11